<unk>  (DHA/PPQ), sold under the brand name Eurartesim among others, is a fixed dose combination medication used in the treatment of malaria. It is a combination of<unk>  and<unk> . Specifically it is used for malaria of the P. falciparum and P. vivax types. It is taken by mouth. Side effects are uncommon. Concerns include the possibility of QT prolongation. Versions are available for use in children. Use in early pregnancy is not recommended. The two medications work by different mechanisms.<unk>  was approved for medical use in Europe in 2011. The combination is on the World Health Organization's List of Essential Medicines. It is commercially available in Africa and Asia. It has been used to treat more than 4.5million people as of 2017.
Piperaquine/dihydroartemisinin
Primaquine
Artesunate/amodiaquine
Amodiaquine
Artemether
Artesunate/mefloquine
Tafenoquine
Mefloquine